Black Hawk Acquisition Corp (BKHA) stock
BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
$8.61−0.04 (-0.46%)
Close on Nov 18, 2026Market cap $35.76MP/E –Yield –
Black Hawk Acquisition operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Black Hawk Acquisition's operating income for the twelve months ending Aug 31, 2026 was -$519.49K. For fiscal 2025 it was -$915.51K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | -$915.51K | – |
| FY2024 | Nov 30, 2024 | -$576.08K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | -$138.21K | – |
| Q2 FY2026CQ2 2026 | May 31, 2026 | -$109.22K | – |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | -$54.19K | – |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | -$217.88K | – |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | -$341.27K | – |
| Q2 FY2025CQ2 2025 | May 31, 2025 | -$247.60K | – |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | -$108.77K | – |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | -$101.27K | – |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | -$84.90K | – |
| Q2 FY2024CQ2 2024 | May 31, 2024 | -$359.20K | – |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | -$30.70K | – |
See a number that looks wrong?